Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Bozena Jarosz"'
Autor:
Ursula Felderhoff-Mueser, Petra Bittigau, Marco Sifringer, Bozena Jarosz, Elzbieta Korobowicz, Lieselotte Mahler, Turid Piening, Axel Moysich, Tilman Grune, Friederike Thor, Rolf Heumann, Christoph Bührer, Chrysanthy Ikonomidou
Publikováno v:
Neurobiology of Disease, Vol 17, Iss 2, Pp 273-282 (2004)
Substantial neurologic morbidity occurs in survivors of premature birth. Premature infants are exposed to partial oxygen pressures that are fourfold higher compared to intrauterine conditions, even if no supplemental oxygen is administered. Here we r
Externí odkaz:
https://doaj.org/article/d885d9a2f0154222b5fd3ee569655b60
Autor:
Mateusz Bilski, Marzanna Ciesielka, Magdalena Orzechowska, Bożena Jarosz, Paulina Całka, Sylwia Bilska, Agata Banach, Gabriela Czaja, Jacek Fijuth, Łukasz Kuncman
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-13 (2024)
Abstract Gliomas are the predominant cause of cancer-related deaths among the young population. Even after incorporation of IDH1/2 mutations and 1p19q codeletion there are doubts regarding adjuvant treatment in WHO G2/G3 gliomas. miRNA molecules cont
Externí odkaz:
https://doaj.org/article/b7f3a899db824a89aa852940bab59e8d
Autor:
Marcin Nicos, Luuk Harbers, Enrico Patrucco, Maximilian Kramer-Drauberg, Xiaolu Zhang, Claudia Voena, Anna Kowalczyk, Aleksandra Bozyk, Rafal Peksa, Bozena Jarosz, Justyna Szumilo, Michele Simonetti, Monika Zuk, Bartosz Wasag, Katarzyna Reszka, Renata Duchnowska, Janusz Milanowski, Roberto Chiarle, Magda Bienko, Pawel Krawczyk, Jacek Jassem, Chiara Ambrogio, Nicola Crosetto
Brain metastases (BM) severely impact the prognosis and quality of life of patients with non-small cell lung cancer (NSCLC). To identify targetable drivers of NSCLC-BM, we profiled somatic copy number alterations (SCNAs) in 51 matched pairs of primar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3c93344cf030b053dcee213568a2801f
https://doi.org/10.21203/rs.3.rs-1320380/v1
https://doi.org/10.21203/rs.3.rs-1320380/v1
Autor:
Michal, Kielbus, Radoslaw, Rola, Bozena, Jarosz, Witold, Jeleniewicz, Marek, Cybulski, Agnieszka, Stenzel-Bembenek, Arkadiusz, Podkowinski, Jolanta, Smok-Kalwat, Krzysztof, Polberg, Tomasz, Trojanowski, Dawid, Stefaniuk, Andrzej, Stepulak
Publikováno v:
Anticancer research. 41(2)
Tumorigenesis and cancer progression might be driven by abnormal activation of growth factor receptors. Importantly, molecular changes in EGFR-dependent signaling is one of the most common characteristics of brain tumors.HER1 and EGFRvIII variants in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cb1f5622ab091c7c507c086109849ab9
https://pubmed.ncbi.nlm.nih.gov/33517305
https://pubmed.ncbi.nlm.nih.gov/33517305
Autor:
Renata Duchnowska, Anna Maria Supernat, Rafał Pęksa, Marta Łukasiewicz, Tomasz Stokowy, Roy Ronen, Janusz Dutkowski, Monika Umińska, Ewa Iżycka-Świeszewska, Anna Kowalczyk, Waldemar Och, Monika Rucińska, Wojciech P. Olszewski, Tomasz Mandat, Bożena Jarosz, Michał Bieńkowski, Wojciech Biernat, Jacek Jassem
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract Brain metastases (BMs) in ovarian cancer (OC) are a rare event. BMs occur most frequently in high-grade serous (HGS) OC. The molecular features of BMs in HGSOC are poorly understood. We performed a whole-exome sequencing analysis of ten matc
Externí odkaz:
https://doaj.org/article/d2d11a695913453e8ed1c77cf42a380f
Autor:
Anna Grenda, Ewelina Iwan, Izabela Chmielewska, Paweł Krawczyk, Aleksandra Giza, Arkadiusz Bomba, Małgorzata Frąk, Anna Rolska, Michał Szczyrek, Robert Kieszko, Tomasz Kucharczyk, Bożena Jarosz, Dariusz Wasyl, Janusz Milanowski
Publikováno v:
AMB Express, Vol 12, Iss 1, Pp 1-7 (2022)
Key points Composition of the microbiome can influence patients response to immunotherapy Response to immunotherapy of NSCLC patients is associated with the presence of Akkermansiaceae in the gut Akkermansia could be used as a predictor for patient t
Externí odkaz:
https://doaj.org/article/18beb8b224e645819cdd58155b18d256
Publikováno v:
Endocrine Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::41981c1a3fe9f40804ceddea031d5207
https://doi.org/10.1530/endoabs.37.ep1298
https://doi.org/10.1530/endoabs.37.ep1298
Publikováno v:
Human Pathology. 32:1304-1308
This feasibility study examined the diagnostic accuracy of Internet-based dynamic-robotic telepathology using neuropathology cases. Randomly, 83 cases were selected from the routine diagnostic workload of the Neurosurgical Pathology Laboratory in Poz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b16ce8d85a4661112faeb10d33890e39
https://doi.org/10.1053/hupa.2001.29647
https://doi.org/10.1053/hupa.2001.29647
Autor:
Paweł Krawczyk, Anna Grenda, Paulina Terlecka, Justyna Błach, Kamila Wojas-Krawczyk, Tomasz Kucharczyk, Izabela Chmielewska, Robert Kieszko, Bożena Jarosz, Michał Gil, Katarzyna Reszka, Janusz Milanowski
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Abstract In patients with advanced non-small cell lung cancer (NSCLC), comprehensive genetic diagnostics is currently carried out in order to qualify for molecularly targeted therapies and immunotherapy. The aim of the study was to assess the usefuln
Externí odkaz:
https://doaj.org/article/0b0280e474be480fb01bad2628801426
Autor:
Marcin Nicoś, PhD, Luuk Harbers, MSc, Enrico Patrucco, PhD, Maximilian Kramer-Drauberg, PhD, Xiaolu Zhang, PhD, Claudia Voena, PhD, Anna Kowalczyk, MD, PhD, Aleksandra Bożyk, PhD, Rafał Pęksa, MD, PhD, Bożena Jarosz, MD, PhD, Justyna Szumiło, MD, Michele Simonetti, PhD, Monika Żuk, PhD, Bartosz Wasąg, MD, Katarzyna Reszka, PhD, Renata Duchnowska, MD, Janusz Milanowski, MD, Roberto Chiarle, MD, Magda Bienko, PhD, Paweł Krawczyk, MD, Jacek Jassem, MD, Chiara Ambrogio, PhD, Nicola Crosetto, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 3, Iss 12, Pp 100435- (2022)
Introduction: Brain metastases (BM) severely affect the prognosis and quality of life of patients with NSCLC. Recently, molecularly targeted agents were found to have promising activity against BM in patients with NSCLC whose primary tumors carry “
Externí odkaz:
https://doaj.org/article/93978b32039848998a35af7844ee33cf